Creo Medical Group (LON:CREO) Reaches New 1-Year Low – What’s Next?

Creo Medical Group PLC (LON:CREO)’s share price hit a new 52-week low during trading on Thursday . The stock traded as low as GBX 12 ($0.15) and last traded at GBX 12 ($0.15), with a volume of 2507958 shares changing hands. The stock had previously closed at GBX 12.88 ($0.17).

Creo Medical Group Stock Performance

The firm has a market cap of £48.51 million, a PE ratio of -1.90 and a beta of 0.86. The business has a 50 day simple moving average of GBX 15.29 and a two-hundred day simple moving average of GBX 18.18. The company has a quick ratio of 2.19, a current ratio of 3.24 and a debt-to-equity ratio of 29.96.

Insider Buying and Selling

In other news, insider Christopher Paul Hancock acquired 4,712 shares of Creo Medical Group stock in a transaction on Monday, January 20th. The shares were bought at an average cost of GBX 19 ($0.25) per share, for a total transaction of £895.28 ($1,154.90). 22.43% of the stock is currently owned by insiders.

About Creo Medical Group

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.

The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.